BioCentury
ARTICLE | Clinical News

Boostrix infectious data

October 24, 2005 7:00 AM UTC

In a double-blind, Havrix-controlled U.S. trial in 2,781 healthy volunteers, Boostrix was 92% effective in protecting at-risk adolescents and adults. Boostrix led to 1 confirmed case of pertussis vs. ...